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Abstract. We have isolated mutants that inhibit mem-
brane protein insertion into the ER membrane of Sac-
charomyces cerevisiae. The mutants were contained in
three complementation groups, which we have named
SEC70, SEC1, and SEC72. The mutants also inhib-
ited the translocation of soluble proteins into the lu-
men of the ER, indicating that they pleiotropically
affect protein transport across and insertion into the
ER membrane. Surprisingly, the mutants inhibited the
translocation and insertion of different proteins to dras-
tically different degrees. We have also shown that mu-
SCENT genetic studies in Saccharomyces cerevisiae
have shown that the SEC61, SEC62, and SEC63
genes are required for secretory protein translocation
into the lumen of the ER (Deshaies and Schekman, 1987;
Rothblatt et al., 1989). These genes were identified because
mutants retained in the cytoplasm a fusion protein that con-
sisted of the prepro region of prepro-a-factor fused to histi-
dinol dehydrogenase (HD),' a yeast cytoplasmic enzyme
required for cells to grow on histidinol. Fused after a signal
sequence, HD was sequestered to the lumen of the ER,
where it was enzymatically inactive in vivo. Selection for
mutant cells containing enzymatically active HD led to the
identification of SEC61, SEC62, and SEC63.
SEC61, SEC62, and SEC63 are essential for cell growth.
The three genes encode distinct ER membrane proteins that
are associated with one another and with other yet uncharac-
terized proteins in a complex (Deshaies et al., 1991). This
complex may form all or part of a polypeptide translocation
apparatus. Mutants in each component of the complex in-
hibitthe translocation of a variety of soluble proteins across
the ER membrane (e.g., the precursors of ci-factor (a secre-
tory protein), immunoglobulin heavy chain binding protein
(BiP) (an ER resident protein), and carboxypeptidase Y
(CPY) (a vacuolar protein) (Deshaies and Schekman, 1987;
Rose et al., 1989; Rothblatt et al., 1989; Sadler et al., 1989) .
1. Abbreviations usedin this paper: BiP, inununoglobulin heavy-chain bind-
ing protein; CPY, carboxypeptidase Y, HD, histidinol dehydrogenase; SRP,
signal recognition particle.
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tations in SEC61 and SEC63, which were previously
isolated as mutants inhibiting the translocation of solu-
ble proteins, also affect the insertion of membrane
proteins into the ER. Taken together our data indicate
that the process of protein translocation across the ER
membrane involves a much larger number of gene
products than previously appreciated . Moreover, differ-
ent translocation substrates appear to have different re-
quirements for components of the cellular targeting
and translocation apparatus.
Interestingly, not all proteins passing through the secretory
pathway were equally affected by mutations in SEC61, SEC-
62, and SEC63; the translocation of pre-invertase showed
little inhibition in mutant cells (Rothblatt et al., 1989) and
the membrane integration of dipeptidylaminopeptidase B
was not affected (Stirling et al., 1992).
Mutants in BiP, an ER lumenal protein (Rose et al., 1989),
and mutants in the cytoplasmic 70K stress proteins also in-
hibitprotein translocation (Deshaies et al., 1988) . Both pro-
teins may interact with the preproteins or with the transloca-
tion apparatus on either side of the membrane to facilitate
membrane translocation.
In contrast to yeast, studies in mammalian systems have
identified different molecular components as important for
protein targeting to and translocation across the ER mem-
brane. Specifically, cytoplasmic signal recognition particle
(SRP), a ribonucleoprotein complex of six protein subunits
and a 7S RNA, and the SRP receptor, a heterodimeric ER
membrane protein, are required for protein translocation
across the mammalian ER membrane in vitro (Walter and
Blobel, 1980; Gilmore et al ., 1982; Meyer et al ., 1982;
Walter and Blobel, 1982) . Other ER membrane proteins
have also been implied to play a role in protein translocation
(Wiedmann et al ., 1987; Krieg et al ., 1989); however, to
date, no mammalian protein homologous to Sec61p, Sec-
62p, or Sec63p has been described. This lack of common
components identified in the different organisms led to the
idea that the mechanism of protein translocation may be fun-
damentally different . Indeed, biochemical studies showed
597that protein translocation in mammalian cells occurs mostly
co-translationally mediatedby SRP and SRP receptor, whereas
yeast ER membranes can translocate certain fully synthe-
sized preproteins posttranslationally without an apparent
need for these components (Hansen et al., 1986; Rothblatt
and Meyer, 1986; Waters and Blobel, 1986) .
Recently, however, the yeast and mammalian studies con-
verged with the discovery of a yeast gene (SRP54) that is ho-
mologous to the 54-kD protein subunit of mammalian SRP
(Bernstein et al ., 1989; Hann et al., 1989; R6misch et al.,
1989). Further studies showed that in yeast an SRP complex
and an SRP receptor exist and, in analogy to their mam-
malian counterparts, function in protein translocation (Hann
and Walter, 1991; S. Ogg, M. Poritz, and P Walter, manu-
script in preparation). Thus with respect to yeast a model is
evolving in which different translocation pathways operate in
parallel. Different translocation substrates may be able to
utilize the different pathways to different degrees; some pro-
teins like prepro-a-factor can be efficiently translocated
posttranslationally and independent of SRP, whereas others
may be more difficult to maintain translocation competent
afterrelease from the ribosome and may therefore strictly re-
quire co-translational targeting by SRP and SRP receptor.
From these results it is apparent that components other
than Sec61p, Sec62p, and Sec63p participate in protein
translocation across the ER membrane, and it is likely that
many other components have not yet been identified. Under
the premise that integral membrane proteins may have re-
quirements for membrane integration distinct from those of
soluble preproteins (such as prepro-a-factor whose prepro
sequence was used in the selection for sec6l, sec62, and
sec63) we engaged in a genetic search for mutants that would
block membrane protein integration. Our genetic selection
mimicked the selection used to identify mutants in SEC61,
SEC62, and SEC63 in that we used fusion proteins that em-
ployed HD as the reporter domain. Our approach differed,
however, in that we used an integral membrane protein as the
targeting domain . As shown in this report, we identified
three novel complementation groups that show pleiotropic
translocation defects. Mutants that fall into these groups
show a surprising degree of substrate specificity. Further-
more, we show that the selection was not exhaustive. It is
therefore likely that other genes involved in the process re-
main to be identified.
Materials andMethods
Antibodies, Reagents, and Media
anti-BiP was obtained from Mark Rose (Princeton University, Princeton,
NJ), anti-invertase fromJohnny Ngsee (Stanford University, Stanford, CA),
anti-a-factor from William Hansen (this lab), and anti-carboxypeptidase Y
from Randy Schekman (University of California, Berkeley, CA). The prep-
aration of anti-HD is described elsewhere (Green and Walter, 1991).
Histidinol was obtained from Sigma Chemical Co. (St. Louis, MO) and
used at a concentration of 10 mM on agar plates. For testing the growth of
cells inthe presence of 10 mM histidinol, agarplates containedSD medium
(0.67% yeast nitrogen base without amino acids, 20 g/liter agar, 20 g/liter
glucose). Supplements included 0.1 mg/ml leucine, 0.1 mg/ml adenine, 0.1
mg/ml tryptophan, and 0.1 mg/ml uracil. Trasylol was obtained from Mo-
bay Corp. (New York) . [35S]Methionine was obtained from ICN Biomedi-
cals Inc. (Irvine, CA).
SD-CAS medium was used for the growth of cells containing plasmids
marked with URA3. SD-CAS contains the same ingredients as SD medium
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plus casaminoacids (0.7%), tryptophan, and adenine (0.1 mg/ml each) . The
casamino acidsupplement contains leucine and histidine, butthe uracil con-
centration is too low for normal cell growth of ura3 mutants. We took ad-
vantage of the low uracil concentration in SD-CAS to detect cells lacking
plasmids marked with URA3 which grew to very small colonies. These
small colonies were then tested for normal growth on SD-CAS agar plates
plus uracil (0.1 mg/ml).
Complementation Analysis
For some ofthecomplementation analyses two procedures were used which
were based on two different phenotypes exhibited by the SEC70, SEC71,
and SEC72 mutants. In the first, a plasmid containing LEU2 and either
SEC61, SEC62, SEC63, or KAR2 was transformed into strains NG30
(sec70-3)/PA255invHD, NG31 (sec71-1)/pA255invHD, and NG32 (sec72-1)/
pA25sinvHD. Transformed cells were detected on agar plates containing
adenine, histidine, and tryptophan (0.1 mg/ml each) as described (Green
and Walter, 1992). Cells were then streaked on similar agar plates except
that 10 mM histidinol was substituted for histidine. Confluent growth on
agar plates containing histidinol was scored as a failure to complement a
sec70, sec71, and sec72 mutation. The plasmids used for this analysis are
described in Table I.
Reduced cell growth rates which are characteristic of SRP54 mutants
(Hann and Walter, 1991) and SEC70, SEC71, and SEC72 mutants were also
used as a phenotype to test forcomplementation. This was doneby crossing
strain BHY147 with strains NG22, NG27, NG28, and the parent strain JCl-
3C. Cells were then cured of pSRP54 (see above). The cells obtained from
all four crosses grew at similar rates, indicating that the new mutants were
not alleles of SRP54. The strains and plasmids used for this analysis are
described in Table I.
Pulse-labeling and Immunoprecipitation
and Western Blot Analysis
Cells were pulse-labeled with [35S]methionine for 5 min at 30°C as de-
scribed elsewhere (Green and Walter, 1992). CSa42 (sec61"), RDMY20
(sec62`5), and D8 (sec63") cells were pulse labeled at the permissive tem-
perature (22°C). Immunoprecipitations and analysis by SDS-PAGE were as
described (Green and Walter, 1992). Prepro-«-factor was detected by West-
ern blot analysis. Cell extracts from NG30 (sec70-3), NG31 (sec71), NG32
(sec72), or IG27-1 (Sec') cells were prepared from cells grown to ODboo
= 1 ml cells were resuspended in 0.2 ml of 10% TCA and broken by vor-
texing with glass beads. The precipitated protein was fractionated by
SDS-PAGE, blotted onto nitrocellulose, and detected with anti-a-factor an-
tibodies followed by alkaline phosphatase-labeled secondary antibodies
(purchased from Bio-Rad, Richmond, CA).
Fusion Protein Constructs
The construction of the plasmids containing gene fusions A's9invHD and
A255invHD were described elsewhere (Green and Walter, 1992) . Sec62p-
Invertase contains an N-terminal fragment (187 residues) of Sec62p fused
to an invertase fragment that contains all of the mature invertase sequence
except for two residues from its N-terminus (Deshaies and Schekman,
1990). Sec63p-Invertase contains an N-terminal fragment (133 residues) of
Sec63p fused to an invertase fragment that contains all ofthe mature inver-
tase except for two residues from its N-terminus (D. Feldheim, personal
communication; Sadler et al., 1989).
Results
Isolation ofMutants
To isolate mutants defective in membrane protein integra-
tion, we used a gene fusion, A255invHD, which encodes the
NH2-terminal 255 amino acids of arginine permease fused
to a spacer comprised of a fragment of cytoplasmic inver-
tase, which in turn was fused to histidinol dehydrogenase
(HD) (Green and Walter, 1992). As depicted in Fig. 1, the
NH2-terminal 255 amino acids of arginine permease con-
tain at leastthree putative transmembrane segments (also see
Green and Walter, 1992). HD catalyses the last step in the
598Table L Strainsand Plasmids Used in This Study
Strain
JC1-3C
FC2-12B
IH27-1
CSa42
RDMY-20
D8
BHY147
NG21
NG22
NG23
NG27
NG28
NG30
NG31
NG32
Plasmid
pA'e'invHD
pAz55invHD
pCS15
pRD 15
pDF26
pMR713
pDF13
pRD33
pDF14
pSRP54
Genotype
MATa, ade5-1, trp-1-1, his4-401, ura3-52, leu2-1, HOL1-1
MATa, trpl-1, leu2-1, ura3-52, his4-401, HOLI-1, canl-1
MATa, his4-401, trpl, ura3, canl, HMRa, HMLa
MATa, sec61-3, his4-401, ura3-52, HOLI-1, trpl-1, leu2-3,-112
MATa, sec62-1, his4-401, ura3-52, HOLI-1, trpl-1, leu2-3,-112
MATa, sec63-1, his4-401, ura3-52, HOLIA, trpl-1, leu2-3,-112
MATa, trpl, lys2, his3, ura3, ade2, srp54::LYS2 + [pSRP54]
MATa, ade5-1, trp-1, his4-401, ura3-52, leu2-1, HOLI-1, sec70-2
MATa, ade5-1, trp-1, his4-401, ura3-52, leu2-1, HOLI-1, sec70-3
MATa, ade5-1, trp-1, his4-401, ura3-52, leu2-1, HOLI-1, sec70-4
MATa, ade5-1, trp-1, his4-401, ura3-52, leu2-1, HOLI-1, sec7l-1
MATa, ade5-1, trp-1, his4-401, ura3-52, leu2-1, HOLI-1, sec72-1
MATa, trpl, his4, ura3, ade5-1,sec70-3, HOLI-I
MATa, trpl, his4-401, ura3,leu2, sec71-1, HOLI-I
MATa, trpl, his4, ura3, leu2, sec72-1, HOLI-I
Markers
CANI ::HIS4, URA3, 2p
CANI ::HIS4, URA3, 2p
SEC61, LEU2, CEN6, ARSH4
SEC62, LEU2, CEN6, ARSH4
SEC63, LEU2, CEN6, ARSH4
KAR2, LEU2, CEN4, ARS1
SEC63 : :SUC2, URA3, 2,u
SEC62 : :SUC2, URA3, 2u
SEC63, LEU2, 211
SRP54, URA3, CEN6, ARSH4
biosynthesis of histidine . When HD is expressed in the
cytoplasm of his4 mutant cells it allows for growth on
histidinol, a metabolic precursor to histidine. A255invHD,
however, did not allow his4 mutant cells to grow
Green et al . Mutations in SEC70, SEC71, and SEC72
on
Figure 1 . Schematic presentation of the proposed topologies of the
membrane fusion proteins . The proposed topologies of A' 89inv-
HD, A255invHD, Sec62p-Invertase, and Sec63p-Invertase in the
ER membrane are schematically indicated (see Materials and
Methods) . Árginine permease, Sec62p, and Sec63p derived se-
quences aredrawn as solid lines . The invertase spacer fragment is
indicated as a striped box, the invertase fragment contained in
Sec62p-Invertase and Sec63p-Invertase is substantially larger. The
HD domain is indicated as a shaded spiral . Core glycosylation is
indicated by black diamonds . Thecartoon attempts to illustrate the
relative transmembrane configurations . An arbitrary number of
core-glycosylation units is shown .
histidinol (Green and Walter, 1992) because uponmembrane
integration of the fusion proteinHD became localized to the
lumen of the ER (see Fig . 1) where it was enzymatically inac-
tive in vivo .
We used the A255invHD fusion construct in a selection
for mutants that would be defective in the proper integration
of this membrane protein . Such mutants would be expected
to retain a sufficient amount of the HD moiety of the fusion
protein in the cytoplasm to allow for growth of his4 mutant
cells on histidinol . For this selection we used the strain JCl-
3C (his4) (Table I) bearing Az55invHD on a plasmid . Five
independent JCl-3C (his4)/pAz 55invHD cell cultures were
mutagenized with ethanemethyl sulfonate (Deshaies and
Schekman, 1987) . One half of the cells were killed by the
mutagenesis . Approximately 106 cells from each culture
were plated on agar plates containing histidinol (see
Materials and Methods ; Parker and Guthrie, 1985) . Twenty
mutant colonies appeared after five to seven days (4 x 10-6
mutational frequency) .
Sincewe were interested in mutations in the cellular mem-
brane protein integration apparatus, we wished to eliminate
plasmid-linked mutations. Mutations linked to pAz 55invHD
would be expected to show a dominant phenotype in diploid
cells . To identify dominant mutations, cells from each of the
twenty colonies were crossed with FC2-12B (his4) cells (Ta-
ble I) . We found that eight of the mutants were recessive,
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Source
Christine Guthrie (University of California,
San Francisco, CA)
Christine Guthrie
John Chant (University of California,
San Francisco, CA)
Colin Stirling (University of California,
Berkeley, CA)
Colin Stirling
Colin Stirling
Byron Hann (University of California,
San Francisco, CA)
This study
This study
This study
This study
This study
This study
This study
This study
Source
Green and Walter (1992)
Green and Walter (1992)
Dave Feldheim and Randy Schekman (University of California,
Berkeley, CA)
Dave Feldheim and Randy Schekman
Dave Feldheim and Randy Schekman
Mark Rose (Princeton University, Princeton, NJ)
Dave Feldheim and Randy Schekman
Dave Feldheim and Randy Schekman
Dave Feldheim and Randy Schekman
Byron Hann (University of California, San Francisco, CA)since the diploid cells derived from the cross did not grow
in the presence of histidinol, but grew when histidine was
added . The other 12 mutants were not examined further.
The haploid cells of the eight recessive mutants were cured
of pA255invHD (see Materials and Methods) and retrans-
formed with pA255invHD. All eight mutants grew on me-
dium containing histidinol, confirming that the recessive
mutations were indeed unlinked to pA255invHD. Two of the
mutants showed a slight temperature-sensitive growth phe-
notype at 37°C ; however, none of the mutations was lethal
at elevated or reduced temperature .
Complementation Analysis
To group the mutations by complementation analysis, each
of the eight mutants was crossed with strain IH27-1 (his4) .
Strain IH27-1 was used because diploid cells were found to
sporulate with high frequency. After sporulation, tetrads
were dissected and then germinated . Each mutation seg-
regated 2:2 (wild-type :mutant) from at least three of four
tetrads suggesting that a single mutant gene was responsible
for cell growth on histidinol . After the cross, each of the
eight mutations was obtained in both MATce and MATa
strains . Thus, we were able to cross each mutant with the
other seven mutants so that all possible combinations were
obtained in diploid cells, which we tested for growth on agar
plates containing histidinol . Six mutants were allelic since
the diploid cells grew on agar plates containing histidinol .
The remaining two mutants were not allelic to each other or
to the other six mutants. Thus, the eight isolated mutations
fall into three complementation groups which we named
SEC70, SEC71, and SEC72 . During the mutant selection
some of the plates contained more than one SEC70 mutant .
Three of the six isolated mutants of SEC70, sec70-2 (strain
NG21 ; Table I), sec70-3 (strain NG22), and sec70-4 (strain
NG23), were isolated from independently mutagenized cell
pools . The SEC71-1 mutant and sec72-1 mutant were named
strains NG27 and NG28 (Table I) . The haploid strains of the
opposite mating type, NG30 (sec70-3), NG31 (sec71-1), and
NG32 (sec72-1) (Table I), were obtained by tetrad dissection
from crosses between strains IH27-1 and NG22, NG27, and
NG28, respectively. To further establish that a single muta-
tion was responsible for growth on histidinol, strains NG30,
NG31, and NG32 were backcrossed with strain JCl-3C/pA2"-
invHD. 10 tetrads were examined from each cross and tested
for growth on histidinol . Each of the 30 tetrads yielded two
germinated spores which grew on agar plates containing
histidinol and two which failed to grow on agar plates con-
taining histidinol . Interestingly, we found that the sec70-3,
sec71-l, and sec72-1 mutations cosegregated with a cell
growth defect . For sec70-3 this defect resulted in colonies on
agar plates that were about one-third the size of the Sec+
strains . This growth defect was about one-half for strains
containing either sec71-1 or sec72-1 .
To determine whether the newly defined complementation
groups are allelic to known translocation mutants, we next
tested whether mutations in SEC61, SEC62, and SEC63,
which block the translocation of soluble proteins across
the ER membrane, would also block the integration ofA"5-
invHD and thus allow his4 mutant cells expressing the fusion
protein to grow on histidinol . It was previously shown that
sec6l ,, , sec62u, andsec63 mutant cells show protein trans-
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location defects evenwhen grown at permissive temperature
(Deshaies and Schekman, 1987 ; Rothblatt et al ., 1989) . We
therefore transformed sec61, sec62, and sec63 mutant cells
with plasmid pA25sinvHD and tested for growth on agar
plates containing histidinol . Strains CSa42 (sec61, his4)/
pA255invHD, and D8 (sec63, his4)/pA255invHD, but not the
control strain JCl-3C (Sec+, his4)/pA 255invHD grew at 22*C
on agar plates containing histidinol . Interestingly, strain
RDMY20 (sec62, his4)/pA255invHD did not grow under
these conditions. This indicated that the tested mutant alleles
ofSEC61 and SEC63, but not that ofSEC62 were defective
in the membrane integration of A255invHD .
These results were confirmed by a biochemical analysis .
A255invHD has been shown to become core glycosylated
upon localization of theHD domain to the ER lumen (Green
and Walter, 1992) . We used the molecular weight shift as-
sociated with the glycosylation ofA 25sinvHD as an indica-
tor of membrane integration . Sec+ and sec61, sec62, and
sec63 mutant cells bearing pA255invHD were pulse labeled
with [35S]methionine, and A255invHD was immunoprecipi-
tated with anti-HD antibodies (Green and Walter, 1992) . In
agreement with the genetic data described above, a faster
migrating band corresponding to unglycosylated A255invHD
was obtained in the sec61 and sec63 mutant strains (Fig . 2,
lanes 2 and 4) . This band comigrated exactly with in vitro
translated A255invHD (not shown ; Green and Walter, 1992) .
Note that a small amount of unglycosylated A25sinvHD was
also detected in the Sec+ control strain and the sec62 mu-
tant strain (Fig . 2, lanes 1 and 3) . This indicated that some
HD was present in the cytoplasm in the Sec+ control cells,
Figure 2. Analysis of A255invHD in sec61, sec62, and sec63 cells .
JCl-3C (Sec+)/pA255invHD cells (lane 1), CSa42 (sec61-3)l
pA255invHD cells (lane 2), RDMY20 (sec621)/pA255invHD cells
(lane 3), and D8 (sec631)/pA 255invHD cells (lane 4) were pulse
labeled with [35S]methionine at the permissive temperature as de-
scribed (see Materials and Methods and Green and Walter, 1992) .
Proteins were precipitated with anti-HD antibodies and displayed
by SDS-PAGE . The position of A255invHD and glycosylated
A 255invHD (A2.ssinvHD*CHO) are indicated .
600Figure 3 Analysis of Az 55invHD in sec70, sec71, and sec72 cells.
As described in Fig . 2, Az55invHD was immunoprecipitated from
pulse-labeled NG22 (sec70-3)/pAz55invHD cells (lane 3), NG27
(sec71-1)/pAz55invHD cells (lane 4), and NG28 (sec72-1)/pAz55 -
invHD cells (lane S), and as controls, from CSa42 (sec61-3)l
pA255invHD cells (lane 6), JCl-3C (Sec+)/pAz55invHD cells (lane
2), and JCl-3C (Sec') cells that did not contain a plasmid (lane 1) .
Proteins were precipitated with anti-HD antibodies and displayed
by SDS-PAGE . The position of Az 55invHD and glycosylated Az55-
invHD (A2 s5invHD*CHO) are indicated.
although the genetic data indicated that this level was
insufficient to support growth on histidinol .
Since the membrane integration of Az 55invHD was im-
paired in sec61 and sec63 mutant strains, it was important
to test whether any of the newly identified mutants were al-
lelic to the known translocation mutants . CSa42 (sec6l,
his4) was crossed with strains NG30 (sec70, his4)/pAz55-
invHD, NG31 (sec71, his4)/pAz55invHD, and NG32 (sec72,
his4)/pAz55invHD and, analogously, strain D8 (sec63, his4)
was crossed with strains NG21 (sec70, his4)/pA"5invHD,
NG27 (sec71, his4)/pAz55invHD, and NG28 (sec72, his4)/
pAz55invHD. None of the diploid cells derived from these
crosses grew on agar plates containing histidinol, thus indi-
cating that the mutants complemented each other. We can
therefore conclude that sec70-3, sec71-1, and sec72-1 are not
allelic to sec61-3 and sec63-1 . The sec62 mutant strain could
not be similarly tested, since the integration of Az 55invHD
was not impaired in sec62 cells (see above and Fig . 2,
lane 3) .
In the second test, sec70, sec71, and sec72 mutant cells
were transformed with low copy number plasmids (CEN)
bearing the wild-type genes of SEC61, SEC62, and SEC63
and were tested for growth on histidinol (see Materials and
Methods) . Each of the transformed mutants grew on agar
plates containing histidinol, indicating that SEC61, SEC62,
and SEC63 did not complement the sec70, sec71, and sec72
defects . Furthermore, the transformed mutants exhibited a
reduced growth rate, described above, that is characteristic
of the sec70, sec71, and sec72 defects . A multi-copy plasmid
Green et al . Mutations in SEC70, SEC71, andSEC72
containing SEC63, pDF14, was transformed into strain
NG31(sec71-1)/pAz 55invHD, and cells were tested for growth
on agar plates containing histidinol . These cells grew to
small colonies compared to cells that were placed on agar
plates containing histidine, indicating that the overproduc-
tion ofSEC63 may have partially compensated for the defec-
tive insertion of Az55invHD into the ERmembrane . In simi-
lar experiments we determined that none of the three new
complementation groups was allelic to SRP54 or to KAR2
encoding BiP, which was recently shown (Rose et al., 1989)
to play a role in ER protein translocation (see Materials and
Methods) .
Analysis ofMembrane Protein Integration
in sec70, sec71, and sec72 Cells
To corroborate the genetically inferred membrane protein
integration defect of sec70, sec71, and sec72 cells, we assayed
the integration of Az55invHD directly by immunoprecipita-
tion . As shown in Fig . 3, JCl-3C (Sec+)/pA"5invHD cells
contained predominantly the glycosylated form of Az 55invHD
(Fig . 3, lane 2) and, as expected, no immunoreactive band
was detected in JCl-3C control cells lacking the plasmid
(Fig . 3, lane 1) . As described above, a small amount ofungly-
cosylated Az55invHD was also present in JCl-3C (Sec+)/
pA255invHD cells (Fig . 3, lane 2) . In contrast, however, sec70,
sec71, and sec72 mutant cells contained markedly increased
amounts of the unglycosylated form of Az 55invHD (Fig . 3,
lanes 3, 4, and 5, respectively) . As shown above, sec61 cells
accumulated almost exclusively the non-glycosylated form of
Az55invHD (Fig . 3, lane 6) . These results lend strong support
to the notion that sec70, sec71, and sec72 mutant cells are in-
deed defective in the membrane integration of Az 55invHD.
We repeated the immunoprecipitation of A215invHD from
mutant strains obtained from two backcrosses against Sec+
strains (see above), and similar results were obtained (data
not shown) .
We next tested whether a similar defect could also be ob-
served for other membrane protein constructs . First we
tested A'g9invHD (Fig. 1) which is similar to Az55invHD,
but only contains the NH2-terminal 189 amino acids of ar-
ginine permease. As indicated in Fig . 1, A 119invHD lacks
two putative transmembrane segments which are present in
Az55invHD. Both A'89invHD and Az55invHD place the HD
domain on the lumenal side of the ER membrane (Green and
Walter, 1992) . A' 89invHD products synthesized in vivo
were analyzed as above by immunoprecipitation after pulse
labeling of cells. As expected, in Sec+ control cells all of
the A 1a9invHD was immunoprecipitated as the glycosylated
form (Fig . 4 A, lane 1), whereas in CSa42 (sec61-1)/
pA'89invHD cells all of the A119invHD was found in the
non-glycosylated form (Fig . 4 A, lane 5) which comigrated
with the in vitro translation product (not shown) . The corre-
sponding analysis ofNG27 (sec71-1)/pA 119invHD and NG28
(sec72-1)/pA119invHD cells (Fig . 4 A, lanes 3and 4) showed
that both mutants were severely impaired in the membrane
integration of A189invHD and accumulated considerable
amounts of the unglycosylated form of the protein . Surpris-
ingly, however, NG22 (sec70-3)/pA189invHD cells showed
no detectable defect in the integration of the fusion protein
(Fig. 4 A, lane 2) . Thus the sec70-3 mutation appears to in-
hibit selectively the integration ofAz55invHD, but not ofA' 89 -
invHD (compare Fig . 3, lanes 3 with Fig . 4A, lane 2) . Simi-
60 1figure 4 . Analysis of other membrane fusion proteins in sec70, sec71, and sec72 cells . (A) As described in Fig. 2, A'a9invHD was im-
munoprecipitated from pulse-labeled NG22 (sec70-3)/pA'89invHD cells (lane 2), NG27 (sec711)/pA' 89invHD cells (lane 3), and NG28
(sec721)/pA' 89invHD cells (lane 4), and as controls, from CSa42 (sec61-3)/pA' 89invHD cells (lane S), and JCl-3C (Sec+)/pA'89invHD
cells (lane 1) . Proteins were precipitated with anti-HD antibodies and displayed by SDS-PAGE . The positions of A'89invHD and gly-
cosylated A' 89invHD (A 189invHD*CHO) are indicated . (B) Sec63p-Invertase was inununoprecipitated from pulse-labeled NG22 (sec70-3)/
pDF13 cells (see Table I) (lane 2), NG27 (sec711)lpDFl3 cells (lane 3), and NG28 (sec721)/pDFl3 cells (lane 4), and as control, from
JCl-3C (Sec+)/pDF13 cells (lane 1) . Proteins were precipitated with anti-invertase antibodies and displayedby SDS-PAGE . The positions
of Sec63p-Invertase and glycosylated Sec63p-Invertase (Sec63p-Invertase*CHO) are indicated .
larly, the analysis of the other two alleles of sec70 showed
no accumulation of unglycosylated A'89invHD for sec70-2
and only a very minor effect for sec70-4 (data not shown) .
Very similar results were obtained when the integration of
a Sec63p-Invertase fusion protein (see Materials and Meth-
ods) (contained on the plasmid pDFl3) (Table I) was tested
in the mutant strains . The membrane topology of Sec63p-
Invertase is shown in Fig . 1 . Note that after pulse labeling
the Sec+ control cells and NG22 (sec70-3)/pDF13 cells ac-
cumulate mostly the glycosylated, i.e ., integrated form of
Sec63p-Invertase (Fig. 4 B, lanes 1 and 2) . In contrast,
NG27 (sec71-1)/pDF13 and NG28 (sec72-1)/pDFl3 cells ac-
cumulate substantial amounts of the unglycosylated, i .e .,
non-integrated form of Sec63p-Invertase (Fig . 4 B, lanes 3
and 4) . A fourth membrane protein tested was a Sec62p-
Invertase fusion (Fig . 1), which, interestingly, showed no in-
tegration defect inNG22 (sec70-3), NG27 (sec71-1), or NG28
(sec72-1) cells (data not shown) .
Thus the integration of the different chimeric membrane
proteins was impaired differentially by the sec70, sec71, and
sec72 mutations . These data are summarized in Table II .
There is no obvious correlation between the presumedmem-
brane protein topology (Fig . 1) and the severity of the defect
in the different mutant strains.
Analysis ofProtein Translocation in sec70, sec71,
andsec72 Cells
We have shown above that mutations that block the translo-
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cation of secretoryproteins across theERmembrane also in-
hibited the integration of membrane proteins (Fig. 2) . We
were therefore interested to test whether, conversely, themu-
tants isolated as membrane protein integration defective
Table IL Inhibition ofProtein Insertion into the ER*
* Protein insertion was detected by immunoprecipitating each protein from
either NG30, NG31, or NG32 cells, and then testing for glycosylation or, for
BiP, for signal cleavage after a 5-min pulse of [35S]methionine . a-Factor was
detected by Western blotting as detailed in Materials and Methods and in Fig .
5 C . Strains NG22, NG27, and NG28 were used for the immunoprecipitations
of A' 89invHD, Az55invHD, and invertase . Themembrane protein insertion as-
say for glycosylation measured only the translocation of the extracytoplas-
mic domains; the insertion of other segments were not tested . A' 89invHD,
A2"invHD, Sec63p-Invertase, and Sec62p-Invertase were plasmid encoded .
The other proteins were encoded in single copy by chromosomal genes .
t (+) indicates insertion was inhibited by 10% or less . (++) Indicates inser-
tion was inhibited by 10 to 50% . (+++) Indicates insertion was inhibited by
more than 50% .
§ In the case of invertase, a small amount of pre-invertase (<10%) was de-
tected in sec70-3 cells in two out of three independent experiments .
602
Protein sec70-3 sec71-1 sec72-1
pAz55invHD +++# +++ +++
Sec63p-Invertase - ++ +
pA's 1invHD - ++ + ++
Sec62p-Invertase - - -
a-factor + + ++
BiP ++ - -
CPY + +++ ++
Invertase -3 - -would also block the complete translocation of soluble pro-
teins. We tested for the accumulation of untranslocated pro-
teins in the strains NG30 (sec70-3), NG31 (sec71-1), and
NG32 (sec72-1) . Fig . 5 shows the analysis for carboxypepti-
dase Y (CPY, a vacuolar protein), BiP (encoded by KAR2,
a soluble ER resident protein), and pro-a-factor (a secretory
protein) . Note that the translocation of CPY and pro-a-
factor was impaired in all three mutant strains, as apparent
from the accumulation of unglycosylated preproCPY (Fig .
5 A, lanes 2-4) and unglycosylated prepro-a-factor (Fig . 5
C, lanes 2-4) . Similar defects were observed in CSa42
(sec61-1) cells (Fig . 5, A and C, lanes 5), but not in control
Sec+ cells (Fig. 5, A and C, lanes 1) . A very different result
was obtained when the translocation of BiP was assessed in
these cells . BiP is not glycosylated and therefore the accu-
mulation of a slower migrating form, preBiP, containing
the uncleaved signal sequence is indicative of a translocation
defect . Note that only NG30 (sec70-3) cells show an accu-
mulation ofpreBiP (Fig . 5 B, lane 2), whereas BiP appeared
efficiently translocated in NG31 (sec71-1) and NG32 (sec72-1)
cells (Fig . 5 B, lanes 3 and 4) and in Sec+ control cells (Fig.
5 B, lane 1) . A fourth soluble protein, invertase, was not de-
tectably impaired in sec70-3, sec71-1, and sec72-1 mutant
cells (data not shown) .
Discussion
Mutations in SEC70, SEC71, andSEC72 were selected using
a strategy designed to find mutants that were impaired in
their ability to integrate a membrane protein . During the
analysis of the mutant cells we found that mutations in each
of the three new complementation groups also blocked the
translocation of soluble proteins across the ER membrane .
This shows that the defects observed in these mutants were
not restricted to membrane protein integration, but more
Green et al . Mutations in SEC70, SEC71, andSEC72
Figure 5. Analysis ofCPY, BiP, and pro-a-factor in sec70, sec71, and sec72 cells .
(A and B) Cell labeling and immunoprecipitations were performed as described
in Fig . 2, except that either 1 jt,l of anti-CPY serum (A) or 0.5 I1 of anti-BiP
serum (B) were used . Analyses were from JCl-3C (Sec') cells (lanes 1), NG30
(sec70-3) cells (lanes 2), NG31 (sec- 71-1) cells (lanes 3), NG32 (sec721) cells
(lanes 4) and CSa42 (sec61-3) cells (A, lane 5) . The positions of prepro-CPY
(ppCPY), glycosylated proCPY (pCPY*CHO), pre-BiP and mature BiP are indi-
cated . (C) Pro-a-factor was detected by Western blotting as described in Ma-
terials and Methods in JCl-3C (Sec) cells (lane 1), NG30 (sec70-3) cells (lane
2), NG31 (sec711) cells (lane 3), NG32 (sec721) cells (lane 4), and CSa42
(sec61-3) cells (lane 5) . The positions of cytoplasmic prepro-a-factor (ppaF)
and glycosylated pro-a-factor (puF*CHO) are indicated .
pleiotropically impaired protein traffic across the ER mem-
brane . Since the soluble proteins that were monitored in this
analysis were encoded by their endogenous chromosomal
genes, this demonstrated that the effects of the mutations
were not limited to the membraneproteins tested which were
artificial fusion proteins encoded by plasmids .
Our data did not address the questions of whether the ob-
served mutant phenotypes were due to defective targeting of
the proteins to theERmembrane or due to a defective mem-
brane integration/translocation machine. In vitro assays using
membrane and soluble fractions of mutant cell extracts and
characterizations of the affected gene products after identi-
fication, cloning, and genetic manipulation will directly ad-
dress this issue . Progress toward this goal has been made.
We have recently cloned and sequenced a gene that comple-
ments the sec71 mutant . This gene encodes a 87-kD hydro-
philic protein ofunknown function .
The mutations in SEC70 (identified by three indepen-
dently isolated alleles) conferred a remarkable phenotype :
cells correctly localized the HD moiety of A' 89invHD to the
extracytoplasmic side of the ER membrane, but showed an
increased mislocalization of the HD moiety of Az55invHD
(Figs . 3 and 4) . Since Az55invHD differs from A' 89invHD
only by the additional presence of two putative transmem-
brane segments, this suggests that SEC70 function may be
specifically required to facilitate the proper integration of
these latter hydrophobic protein segments . Thus we would
predict that the SEC70 gene product exerts its function at the
ER membrane during the translocation/integration process .
This interpretation appears most plausible since A 119invHD
was correctly targeted to the ER and Az 55invHD contained
all the same targeting signals contained in A' 89invHD, in-
cluding an internal signal sequence identified previously
(Green et al ., 1989) . However, it still remains possible that,
despite these similarities, A 189invHD may have been tar-
geted to the ER membrane by a different pathway than that
603used by Az55invHD, one that was not impaired in sec70 mu-
tants.
Surprisingly, different membrane and soluble proteins
were impaired to different degrees during their integration
into or translocation across the ER membrane in the different
mutant strains (see Table II) . There is no obvious pattern
emerging that would allow us to categorize the substrate pro-
teins and thus to predict whether a given protein would be
affected by a particular mutation . Rather it appears from
these data that individual proteins are differentially sensitive
to the mutations. This could imply that different cellular
components may be used in different pathways that lead to
the trafficking of proteins to and across the ER membrane.
For example, our data suggest that BiP can be translocated
efficiently across the ER membrane without SEC71 and
SEC72 function, whereas Sec63p-Invertase can be inserted
into the membrane without SEC70 function. Alternatively,
all the gene products defined by the mutations collaborate in
the targeting and translocation process of all protein sub-
strates, but subtle defects in the isolated alleles produce more
pronounced translocation defects for some proteins, yet are
silent for others.
It is clear from these data, that the requirements on the
translocation machine differ vastly for different translocation
substrates. Whether these differences are due to different sig-
nal sequences or different passenger domains remains to be
analyzed by altering these parameters systematically. Intrig-
uingly, none ofthe mutations identified to date, i.e., the mu-
tations described here and mutations in SEC61, SEC62, and
SEC63 (Rothblatt et al., 1989) shows a marked inhibition of
pre-invertase translocation. Thus for unknown reasons, in-
vertase appears to be a particularly permissivetranslocation
substrate.
Since cells mutant in SEC61 and SEC63 also showed
defects in the membrane integration of Az55invHD, we ex-
pected our selection to yield mutations in these genes. Sur-
prisingly however, none of our mutants was complemented
by SEC61, SEC62, and SEC63. Similarly, the selection ap-
plied by Schekman and co-workers in which sec61, sec62
and sec63 mutants were isolated did not identify other genes
which are now known to be involved in protein targeting and
translocation, such as BiP (Rose et al., 1989) and compo-
nents in the SRP-dependent targeting pathway (Hann and
Walter, 1991; S. Ogg, M. Poritz, and P Walter, manuscript
in preparation) . It is possible that using a different transloca-
tion substrate or using less stringent selection criteria (e.g.,
we did not require our mutants to be conditionally lethal)
have allowed us to identify new complementation groups.
Given the small number of mutants isolated and our failure
to isolate mutations in SEC61, SEC62, and SEC63, it is
clear that this selection has not been exhaustive and that
many as yet unidentified genes may also participate in pro-
tein transport across or integration into the ER membrane.
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